ADMA BIOLOGICS, INC. — Director's Dealing 2012

Feb 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: R&R ACQUISITION VI, INC (NONE)
CIK: 0001368514
Period of Report: 2012-02-13

Reporting Person: Burrill Capital Fund IV, L.P. (Director, 10% Owner)
Reporting Person: BURRILL STEVEN (Director, 10% Owner)
Reporting Person: WETHERELL DAVID S (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-13	Common Stock, par value $0.0001 per share	A	885417	—	Acquired	885417	Indirect

Footnotes

F1: On February 13, 2012, the issuer's wholly-owned subsidiary merged with ADMA Biologics, Inc., a privately-held Delaware corporation ("Former ADMA"). The issuer changed its name to ADMA Biologics, Inc. In connection with the merger and pursuant to the terms of the merger agreement, holders of Former ADMA's common stock received the same number of shares of the issuer's common stock. The reporting person, an investor in Former ADMA's private placement, which closed immediately prior to the merger, acquired the issuer's shares of common stock in exchange for the shares purchased in the private placement. The issuer's shares of common stock are not currently listed on an exchange or quoted on the OTC Bulletin Board.

F2: These shares are held of record by Burrill Capital Fund IV, L.P ("Burrill") and are deemed to be beneficially owned by Burrill & Company (BCF IV GP), LLC ("Burrill GP"), and each of the individual managing members of Burrill GP. The individual managing members of Burrill GP are G. Steven Burrill and David S. Wetherell (the "Managers"). Burrill GP and the Managers may share voting and dispositive power over the shares owned of record by Burrill. Burrill GP and the Managers disclaim beneficial ownership over such shares except to the extent of their respective pecuniary interest therein.